Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Exchange Rate Effect (2023 - 2025)

Aethlon Medical filings provide 3 years of Exchange Rate Effect readings, the most recent being -$2422.0 for Q1 2025.

  • On a quarterly basis, Exchange Rate Effect fell 7.31% to -$2422.0 in Q1 2025 year-over-year; TTM through Mar 2025 was -$12262.0, a 681.96% decrease, with the full-year FY2025 number at -$12262.0, down 681.96% from a year prior.
  • Exchange Rate Effect hit -$2422.0 in Q1 2025 for Aethlon Medical, up from -$13635.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $5605.0 in Q4 2023 to a low of -$13635.0 in Q4 2024.
  • Median Exchange Rate Effect over the past 3 years was -$1290.0 (2024), compared with a mean of -$1790.2.
  • The widest YoY moves for Exchange Rate Effect: up 581.99% in 2024, down 593.55% in 2024.
  • Aethlon Medical's Exchange Rate Effect stood at $5605.0 in 2023, then tumbled by 343.26% to -$13635.0 in 2024, then surged by 82.24% to -$2422.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$2422.0 (Q1 2025), -$13635.0 (Q4 2024), and $5085.0 (Q3 2024) per Business Quant data.